|
|
|
|
LEADER |
00833cam a2200229 a 4500 |
001 |
INLIS000000000253170 |
005 |
20101230101212.12 |
006 |
aa###g#####i00000# |
007 |
ta |
008 |
101230s1983####fr#a###g#####i00000#eng## |
035 |
# |
# |
|a 0010-45024260
|
040 |
# |
# |
|a JKPNPNA
|b eng
|
041 |
0 |
# |
|a eng
|
082 |
0 |
4 |
|a 616.994
|
090 |
# |
# |
|a U.N. : -1703-2000 No. 67
|
111 |
2 |
# |
|a IARC Working Group on the Evaluation of Carcinogenic Risks Humans
|d [1996 :
|c Lyon, France]
|
245 |
1 |
0 |
|a Human immuno deficiency viruses and human T-cell lymphotropic viruses :
|b IARC Working Group on the Evaluation of Carcinogenic Risks Humans which met in Lyon, 15-22 February 2000
|
650 |
# |
4 |
|a Karsinogenesis
|
710 |
2 |
# |
|a International Agency for Research on Cancer
|
900 |
# |
# |
|a 00597nbm**2200012*a*4500
|
902 |
# |
# |
|a 131906177:30-DEC-10*
|
999 |
# |
# |
|a 415/TIR/MS/2000
|